Joel van Roon

Associate Professor

Strategic program(s):

Contact

jroon@umcutrecht.nl

Pure profile

Recent publications

All publications

CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren’s Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells Anneline C. Hinrichs, Aike A. Kruize, Floris P.J.G. Lafeber, Helen L. Leavis, Joel A.G. van Roon
International Journal of Molecular Sciences, 2023, vol. 24

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response Safae Hamkour, Eefje Hm van der Heijden, Ana P Lopes, Sofie L M Blokland, Cornelis P J Bekker, Cornelia G Van Helden-Meeuwsen, Marjan A Versnel, Aike A Kruize, Timothy Rdj Radstake, Helen L Leavis, Maarten R Hillen, Joel Ag van Roon
RMD Open, 2023, vol. 9

Deciphering the role of cDC2s in Sjögren's syndrome Ana P Lopes, Maarten R Hillen, Anneline C Hinrichs, Sofie Lm Blokland, Cornelis Pj Bekker, Aridaman Pandit, Aike A Kruize, Timothy Rdj Radstake, Joel A van Roon
Annals of the Rheumatic Diseases, 2022, vol. 82, p.374-383

CXCL4 drives fibrosis by promoting several key cellular and molecular processes Alsya J Affandi, Tiago Carvalheiro, Andrea Ottria, Judith J de Haan, Maike A D Brans, Maarten M Brandt, Ralph G Tieland, Ana P Lopes, Beatriz Malvar Fernández, Cornelis P J Bekker, Maarten van der Linden, Maili Zimmermann, Barbara Giovannone, Catharina G K Wichers, Samuel Garcia, Michael de Kok, Giuseppina Stifano, Yan Juan Xu, M Anna Kowalska, Maaike Waasdorp, Caroline Cheng, Susan Gibbs, Saskia C A de Jager, Joel A G van Roon, Timothy R D J Radstake, Wioleta Marut
Cell Reports, 2022, vol. 38

The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint Disease E M van Helvoort, E van der Heijden, J A G van Roon, N Eijkelkamp, S C Mastbergen
Cartilage, 2022, vol. 13, p.1-14

In patients with primary Sjögren’s syndrome innate-like MAIT cells display upregulated IL-7R, IFN-γ, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells Anneline C Hinrichs, Aike A Kruize, Helen L Leavis, Joel A G van Roon
Frontiers in Immunology, 2022, vol. 13